Insider Trading July 9, 2026 04:18 PM

Saba Capital Reduces BlackRock ESG Capital Allocation Term Trust Holding

Asset manager offloads $633,076 in ECAT shares following recent Form 4 filings, leaving a substantial remaining position in the closed-end fund.

By Nina Shah
Share
Twitter Reddit Facebook LinkedIn
ECAT

Saba Capital Management, L.P., which maintains a 10% stake in BlackRock ESG Capital Allocation Term Trust (NYSE: ECAT), has executed a series of share disposals totaling $633,076. According to recent regulatory filings, the fund management firm reduced its position over a two-day period in early July 2026. This activity follows a period where the trust has delivered an 18% return over the past year, despite trading approximately 8% below its 52-week high. The trust is known for its high dividend yield, which stands at 20.6%, and has increased its dividend for five consecutive years. Following these transactions, Saba Capital retains a significant holding of 17,425,487 shares in the common stock of the trust.

Saba Capital Reduces BlackRock ESG Capital Allocation Term Trust Holding
ECAT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Saba Capital Management sold 40,616 shares of ECAT over two days in July 2026, totaling $633,076.
  • The trust currently trades at $15.76, which is 8% below its 52-week high of $17.14, but has delivered an 18% return over the past year.
  • ECAT offers a 20.6% dividend yield and has increased its dividend for five consecutive years, maintaining investor interest in high-yield strategies.

Saba Capital Management, L.P., a notable 10% shareholder in BlackRock ESG Capital Allocation Term Trust, has executed a series of sales involving the trust's common stock. The total value of these divestments amounts to $633,076, according to a Form 4 filing submitted to the Securities and Exchange Commission. The transactions were completed over a two-day period, marking a specific reduction in the firm's equity position within the trust.

On July 7, 2026, Saba Capital Management disposed of 1,397 shares of common stock. The execution price for these shares was recorded at $15.78 per share. The following day, July 8, 2026, the firm sold an additional 39,219 shares. These subsequent shares were transacted at a price of $15.58 per share. The pricing for the total volume of sold shares ranged between $15.58 and $15.78 per share.

Market data indicates that the trust currently trades at $15.76. This current valuation places the security approximately 8% below its 52-week high of $17.14. Despite this proximity to its recent peak, the trust has generated an 18% return over the past year. Financial data from InvestingPro Tips highlights that ECAT provides a substantial dividend to its shareholders, boasting a yield of 20.6%. Furthermore, the trust has raised its dividend for five consecutive years, demonstrating a history of increasing shareholder payouts.

Following the completion of these recent transactions, Saba Capital Management, L.P. continues to hold a significant position in the trust. The firm retains ownership of 17,425,487 shares of BlackRock ESG Capital Allocation Term Trust common stock. This remaining stake underscores the firm's continued, albeit reduced, exposure to the closed-end fund.

Risks

  • The trust is trading 8% below its 52-week high, which may indicate short-term price volatility or downward pressure on the valuation.
  • High dividend yields of 20.6% can sometimes signal market concerns about the sustainability of payouts or underlying asset quality, requiring close monitoring of the fund's credit risk and asset allocation.
  • Regulatory filings show specific selling activity, which may reflect fund-level rebalancing or strategic adjustments by the asset manager, potentially impacting market sentiment for the security.

More from Insider Trading

Oregon Community Foundation Reduces Stake in Jewett Cameron Trading Co Jul 9, 2026 HRT Financial Disposes of Shuttle Pharmaceuticals Holdings Amid Merger Activity and Stock Split Jul 9, 2026 HRT Financial Reduces Wheeler REIT Stake Amid Portfolio Restructuring Jul 9, 2026 Immunome Executive Liquidates Position as Pipeline Developments Advance Jul 9, 2026 AtaiBeckley Director Robert Hershberg Executes Pre-Arranged Sale Following Option Exercises Jul 9, 2026